CPAP vs mandibular advancement devices and blood pressure in patients with obstructive sleep apnea a systematic review and meta-analysis

JAMA - Journal of the American Medical Association

Volumn 314, Issue 21, 2015, Pages 2280-2293

  Bratton, Daniel J ^a   Gaisl, Thomas ^a   Wons, Annette M ^a   Kohler, Malcolm ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE EFFECTIVENESS; DEVICE THERAPY; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MANDIBULAR ADVANCEMENT DEVICE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SLEEP DISORDERED BREATHING; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; BLOOD PRESSURE; MANDIBLE RECONSTRUCTION; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP APNEA, OBSTRUCTIVE;

BLOOD PRESSURE; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; MANDIBULAR ADVANCEMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SLEEP APNEA, OBSTRUCTIVE;

EID: 84949508475     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.16303     Document Type: Article

References (77)

1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea.AmJ Respir Crit Care Med. 2002;165(9):1217-1239.
2. Kohler M, Stradling J.R. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol. 2010;7(12):677-685.
3. Giles TL, Lasserson TJ, Smith B, et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. doi:10.1002/14651858.CD001106.pub3.
4. B azzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50(2):417-423.
5. F ava C, Dorigoni S, Dalle Vedove F, et al. Effect of CPAP on blood pressure in patients with OSA/hypopnea. Chest. 2014;145(4):762-771.
6. Haentjens P, Van Meerhaeghe A, Moscari ello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome. Arch Intern Med. 2007;167(8):757-764.
7. Montesi SB Edwards BA Malhotra A Bakker JP. The effect of continuous positive airway pressure treatment on blood pressure. J Clin Sleep Med.2012. 8. 5. 587-596.
8. Schein AS, Kerkhoff AC, C oronel CC, et al. Continuous positive airway pressure reduces blood pressure in patients with obstructive sleep apnea. J Hypertens. 2014;32(9):1762-1773.
9. Bennett LS, Davies RJ, Str adling JR. Oral appliances for the management of snoring and obstructive sleep apnoea. Thorax. 1998;53(suppl 2):S58-S64.
10. Iftikhar IH, Hays ER, Iverson MA, et al. Effect of oral appliances on blood pressure in obstructive sleep apnea. J Clin Sleep Med. 2013;9(2):165-174.
11. BarnesM, McEvoy RD, Banks S, et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med. 2004;170(6):656-664.
12. Lam B, Sam K, MokWY, et al. Randomised study of three non-surgical treatments inmild to moderate obstructive sleep apnoea. Thorax. 2007; 62(4):354-359.
13. Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments. BMJ. 2005;331 (7521):897-900.
14. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Intervensions. London, England: Cochrane Collaboration; 2011.
15. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. London, England: Cochrane Collaboration; 2011.
16. Higgins JPT, Deeks JJ, Altman DG. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. London, England: Cochrane Collaboration; 2011.
17. Harris R, BradburnM, Deeks J, et al. Metan: Fixed-and random-effectsmeta-analysis. Stata J. 2008;8(1):3-28.
18. Higgins JP, Thompson SG. Quantifying heterogeneity in ameta-analysis. Stat Med. 2002; 21(11):1539-1558.
19. Harbord RM, Higgins JPT.Meta-regression in Stata. Stata J. 2008;8(4):493-519.
20. Knapp G, Hartung J. Improved tests for a random effectsmeta-regression with a single covariate. Stat Med. 2003;22(17):2693-2710.
21. White IR, Barrett JK, Jackson D, Higgins JPT. Consistency and inconsistency in network meta-analysis. Res Synth Methods. 2012;3(2):111-125.
22. Cipriani A, Higgins JP, Geddes JR, Salanti G. Conceptual and technical challenges in network meta-analysis. Ann Intern Med. 2013;159(2):130-137.
23. White IR. Multivariate random-effects meta-regression. Stata J. 2011;11(2):255-270.
24. Chaimani A, Higgins JPT,Mavridis D, Spyridonos P, Salanti G. Graphical tools for network meta-analysis in STATA. PLoS One. 2013;8(10): E76654.
25. Ari asMA, García-Río F, Alonso-Ferná ndez A, et al. Obstructive sleep apnea syndrome affects left ventricular diastolic function. Circulation. 2005;112 (3):375-383.
26. Barbé F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. Ann Intern Med. 2001;134(11):1015-1023.
27. Barbé F, Durán-Cantolla J, Sá nchez-de-la-Torre M, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea. JAMA. 2012;307(20):2161-2168.
28. BarnesM Houston DWorsnop CJet al. A randomized controlled trial of continuous positive airway pressure inmild obstructive sleep apnea. Am J Respir Crit Care Med. 2002;165, 6, 773-780.
29. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circu lation. 2003;107(1): 68-73.
30. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, et al. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and h ypertension. Chest. 2006;129(6): 1459-1467.
31. Comondore VR, Cheema R, Fox J, et al. The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea. Lung. 2009;187(1):17-22.
32. Coughlin SR,Mawds ley L, Mugarza JA, et al. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J. 2007;29(4): 720-727.
33. Craig SE, Kohler M, Nicoll D, et al. Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea. Thorax. 2012;67(12):1090-1096.
34. Cross MD, Mills NL, Al-AbriM, et al. Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome. Thorax. 2008;63(7):578-583.
35. de Oliveira AC, M artinez D, Massierer D, et al. The antihypertensive effect of positive airway pressure on resistant hypertension of patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2014;190(3):345-347.
36. Drager LF, Bortolotto LA, Figueiredo AC, et al. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2007;176(7):706-712.
37. Drager LF, Pedrosa RP, Diniz PM, et al. The effects of continuous positive airway pressure on prehypertension and masked hypertension in men with severe obstructive sleep apnea. Hypertensi on. 2011;57(3):549-555.
38. Durá n-Cantolla J, Aizpuru F, Montserrat JM, et al. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep a pnoea. BMJ. 2010;341:c5991.
39. Egea CJ, Aizpuru F, Pinto JA, et al. Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea. Sleep Med. 2008;9(6):660-666.
40. Engleman HM, Gough K, Martin SE, et al. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome. Sleep. 1996;19(5):378-381.
41. Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea sy ndrome. Am J Respir Crit Care Med. 2001;163(2):344-348.
42. Gottlieb DJ, Punjabi NM, Mehra R, et al. CPAP versus oxygen in obstructive sleep apnea. N Engl J Med. 2014;370(24):2276-2285.
43. Hall AB, Ziadi MC, Leech JA, et al. Effects of short-term continuous positive airway pressure on myocardial sympathetic nerve function and energetics in patients with heart fai lure and obstructive sleep apnea. Circulation. 2014;130(11): 892-901.
44. Hoyos CM, Killick R, Yee BJ, et al. Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea. Thorax. 2012;67(12):1081-1089.
45. Hoyos CM, Yee BJ,Wong KK, et al. Treatment of sleep apnea with CPAP lowers central and peripheral blood pressure independent of the time-of-day. Am J Hypertens. 2015;28(10):1222-1228.
46. Huang Z, Liu Z, Luo Q, et al. Long-term effects of contin uous positive airway pressure on blood pressure and prognosis in hypertensive patients with coronary heart disease and obstructive sleep apnea. Am J Hypertens. 2015;28(3):300-306.
47. Hui DS, To K W, Ko FW, et al. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness. Thorax. 2006;61(12):1083-1090.
48. IpMS, Tse HF, Lam B, et al. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med. 2004;169(3): 348-353.
49. Jones A, Vennelle M, ConnellM, et al. The effect of continuous positive airway pressure therapy on arterial stiffness and endothelial function in obstructive sleep apnea. Sleep Med. 2013;14(12):1260-1265.
50. Kohler M Stoewhas AC Ayers L et al. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2011. 184.10. 1192-1199.
51. Lam JC, Lam B, Yao TJ, et al. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J. 2010;35(1):138-145.
52. Litvin AY, Sukmarova ZN, Elfimova EM, et al. Effects of CPAP on " vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension. Vasc Health Risk Manag. 2013;9:229-235.
53. Lozano L, Tovar JL, Sampol G, et al. Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension. J Hypertens. 2010;28(10):2161-216 8.
54. Martí nez-GarcíaMA, Capote F, Campos-Rodríguez F, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension. JAMA. 2013;310(22): 2407-2415.
55. McMillan A, Bratton DJ, Faria R, et al. Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT). Lancet Respir Med. 2014;2(10):804-812.
56. Monasterio C, Vidal S, Duran J, et al. Effectiveness of continuous positive airway pressure inmild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med. 2001;164(6):939-943.
57. Muxfeldt ES, Margallo V, Costa LM, et al. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension. Hypertension. 2015;65(4):736-742.
58. Nguyen PK, Katikireddy CK, McConnellMV, et al. Nasal continuous positive airway pressure improvesmyocardial perfusion reserve and endothelial-depen dent vasodilation in patients with obstructive sleep apnea. J Cardiovasc Magn Reson. 2010;12:50.
59. Noda A, Nakata S, Koike Y, et al. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res. 2007;30(8): 669-676.
60. Norman D, Loredo JS, Nelesen R A, et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension. 2006;47 (5):840-845.
61. Pamidi S,Wroblewski K, Ste pien M, et al. Eight hours of nightly continuous positive airway pressure treatment of obstructive sleep apnea improves glucose metabolism in patients with prediabetes. Am J Respir Crit Care Med. 2015;192(1): 96-105.
62. Pedrosa RP, Drager LF, de Paula LK, et al. Effects of OSA treatment on BP in patients with resistant hypertension. Chest. 2013;144(5):1487-1494.
63. Pepp erell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea. Lancet. 2002;359(9302):204 -210.
64. Robinson GV, Smith DM, Langford BA, et al. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J. 2006;27(6):1229-1235.
65. Rossi VA,Winter B, Rahman NM, et al. The effects of Provent on moderate to severe obstructive sleep apnoea during continuous positive airway pressure therapywithdrawal. Thorax. 2013;6 8(9):854-859.
66. Ruttanaumpawan P, Gilman MP, Usui K, et al. Sustained effect of continuous positive airway pressure on baroreflex sensitivity in congestive heart failure patients with obstructive sleep apnea. J Hypertens. 2008;26(6):1163-1168.
67. Takaesu Y, Inoue Y, Komada Y, et al. Effects of nasal continuous positive airway pressure on panic disorder comorbid with obstruct ive sleep apnea syndrome. Sleep Med. 2012;13(2):156-160.
68. Weaver TE, Mancini C, Maislin G, et al. Continuous positive airway pressure treatment of sleepy patients with milder obstr uctive sleep apnea. Am J Respir Crit Care Med. 2012;186(7):677-683.
69. André n A, Hedberg P,Walker-EngströmML, et al. Effects of treatment with oral appliance on 24-h blood pressure in pa tients with obstructive sleep apnea and hypertension. Sleep Breath. 2013; 17(2):705-712.
70. Gotsopoulos H, Kelly JJ, Cistulli PA. Oral appliance therapy reduces blood pressure in obstructive sleep apnea. Sleep. 2004;27(5):934-941.
71. Quinnell TG Bennett M Jordan J et al. A crossover randomised controlled trial of oral mandibular advancement devices for obstructiv e sleep apnoea-hypopnoea (TOMADO) Thorax.2014 69 10 938-945.
72. Phillips CL, Grunstein RR, DarendelilerMA, et al. Health outcomes of continuous positive airway pressure versus oral ap pliance treatment for obstructive sleep apnea. Am J Respir Crit Care Med. 2013;187(8):879-887.
73. Dal-Fabbro C, Garbuio S, D'Almeida V, et al. Mandibular advancement device and CPAP upon cardiovascular parameters in OSA. Sleep Breath. 2014;18(4):749-759.
74. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med. 2002;21(11):1559-1573.
75. Bratton DJ, Stradling JR, Barbé F, Kohler M. Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea. Thorax. 2014;6 9(12):1128-1135.
76. Chirinos JA, Gurubhagavatula I, Teff K, et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med. 2014;370(24):2265-2275.
77. Elbourne DR, Altman DG, Higgins JP, et al. Meta-analyses involving cross-over trials. Int J Epidemiol. 2002;31(1):140-149.